Clinical Trial

Inflammation-Related Endothelial Barrier Dysfunction in Patients With Apical Periodontitis

Completed
View on ClinicalTrials.gov →
Summary
Inflammation is a common factor in chronic periodontitis and systemic diseases. However, to date, there is no scientific evidence supporting a causal effect of inflammation caused by apical periodontitis on endothelial barrier dysfunction. A case-control study was designed to evaluate serum levels of endothelial barrier dysfunction factors in a sample of healthy patients aged 25 to 55, with or without apical periodontitis, before endodontic treatment and 6 and 12 months after treatment. The aim of this study is to investigate the potential relationship between the presence of chronic endodontic lesions and inflammation-related alterations of the endothelial barrier that may compromise its integrity, as well as to determine whether endodontic treatment can reduce these factors, thereby preventing changes in endothelial permeability.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-05.
Trial Details
NCT Number NCT07292363
Lead Sponsor University of Turin, Italy
Conditions Apical Periodontitis, Healhty
Enrollment 45 participants
Start Date 2021-02-09
Primary Completion 2022-04-30 (estimated)
Study Completion 2025-10-16 (estimated)
Updated on ClinicalTrials.gov 2025-12-31